Kymab hires leaders in immuno-oncology, infectious disease and blood disorders Kymab hires leaders in immuno-oncology, infectious disease and blood disorders Appointments bring internationally recognised expertise to strengthen Kymab’s key therapeutic areas Adapt Pharma names Mike Kelly as President of US operations Adapt Pharma names Mike Kelly as President of US operations He contributes more than 25 years of pharmaceutical expertise to Adapt executive team Dr Richard Butt to become CEO of Apollo Therapeutics Dr Richard Butt to become CEO of Apollo Therapeutics He will join the investment fund from Pfizer Neusentis Dr Belinda Quinn appointed as Chief Executive of the Precision Medicine Catapult Dr Belinda Quinn appointed as Chief Executive of the Precision Medicine Catapult Quinn has been Chief Medical Officer of the organisation for the past six months Nigel Bond joins Brother executive management team Nigel Bond joins Brother executive management team Follows acquisition of Domino Printing Sciences by Japanese firm Merck appoints Maya Martinez-Davis as Global Head of Oncology Merck appoints Maya Martinez-Davis as Global Head of Oncology Her role will include defining global oncology strategies and delivering therapeutic launches President of Vetter Development Services USA elected to board of German American Chamber of Commerce of the Midwest President of Vetter Development Services USA elected to board of German American Chamber of Commerce of the Midwest Susanne Resatz will help GACC Midwest further promote and expand bilateral trade and investment between the Midwest and Germany Probiodrug appoints Mark Booth as Chief Business Officer Probiodrug appoints Mark Booth as Chief Business Officer The move expands the German firm's Management Board Novavax announces management promotion Novavax announces management promotion Iksung Cho has been named as Vice President, Biostatistics Daiichi Sankyo appoints Antoine Yver as Global Head, Oncology Research and Development Daiichi Sankyo appoints Antoine Yver as Global Head, Oncology Research and Development He will lead all global R&D across the oncology therapeutic area New Technical Officer for ReFaC New Technical Officer for ReFaC Kim Shillington joins the UK firm ESMO appoints first Chief Medical Officer ESMO appoints first Chief Medical Officer New position reflects ESMO’s rapid growth and follows extensive six-month selection process Paragon Bioservices appoints Bill Thomas as Chief Technology Officer Paragon Bioservices appoints Bill Thomas as Chief Technology Officer Vaccines industry veteran was most recently with MassBiologics Cypralis hires Dr Michael Peel as Chief Scientific Officer Cypralis hires Dr Michael Peel as Chief Scientific Officer He joins the UK life sciences firm from Scynexis, where he was Director of Discovery Valeant Pharmaceuticals makes management change Valeant Pharmaceuticals makes management change In its US Dermatology and Gastrointestinal businesses Rigel names Anne-Marie Duliege as Chief Medical Officer Rigel names Anne-Marie Duliege as Chief Medical Officer Elliott Grossbard retires but will continue advising on NDA filing for fostamatinib New Chief Medical Officer at Arvinas New Chief Medical Officer at Arvinas Angela Shen brings extensive experience in clinical development, medical affairs and business development to the firm HUYA Bioscience appoints John Ratliff as President and CEO HUYA Bioscience appoints John Ratliff as President and CEO He was previously President/COO of Quintiles' Global Services organisation Onxeo establishes US subsidiary Onxeo establishes US subsidiary Pharmaceutical and biotech industry veteran, Philippe Maitre, will head the new venture Sanofi appoints Dr Yong-Jun Liu as Head of Research Sanofi appoints Dr Yong-Jun Liu as Head of Research He will be responsible for leading all of Sanofi's research with the goal of delivering innovative and high-value medicines for patients Quay Pharma celebrates apprentice success Quay Pharma celebrates apprentice success The firm's Apprenticeship Scheme has made an important contribution to the ongoing growth and development of its business Michael Luther joins Bantam Pharmaceutical as President and CEO Michael Luther joins Bantam Pharmaceutical as President and CEO Prior to this he was SVP and General Manager for the Discovery and Development Services Division of Albany Molecular Research Two executives join Transgene leadership team Two executives join Transgene leadership team Maud Brandely and John Felitti join the French firm Sosei appoints Peter Bains as COO and President elect Sosei appoints Peter Bains as COO and President elect He is expected to become Representative Executive Officer, President and Chief Executive at the AGM in June